Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).

Graphene oxide (GO)-based nanosheets with combined chemo/photothermal/photodynamic therapy to overcome gastric cancer (GC) paclitaxel resistance by reducing mitochondria-derived adenosine-triphosphate (ATP).
复制标题

DOI:
10.1186/s12951-021-00874-9
复制
发表时间:
2021-05-19
影响因子:
10.2
通讯作者:
Hu Y
Hu Y
中科院分区:
工程技术1区
文献类型:
--
作者:
Guo W;Chen Z;Feng X;Shen G;Huang H;Liang Y;Zhao B;Li G;Hu Y

文献摘要

参考文献

被引文献

相似文献

紫杉醇(PTX)是治疗胃癌的一线药物,而P-糖蛋白(P-gp)可将PTX泵出胃癌细胞,导致胃癌耐药。因此,通过抑制P-gp的外泵功能来对抗耐药可能是一条有希望的途径。在这项研究中,我们开发了一种药物递送系统,将PTX结合到聚乙二醇(PEG)修饰和氧化海藻酸钠(OSA)功能化的氧化石墨烯(GO)纳米片(NS)上,称为PTX@GO-PEG-OSA。由于PTX@GO-PEG-OSA具有pH/温度敏感性释药特性,与游离PTX相比,PTX@GO-PEG-OSA对GC具有更明显的抗肿瘤作用。PTX@GO-PEG-OSA在近红外(NIR)照射下可产生过量的活性氧(ROS),攻击线粒体呼吸链复合酶,减少P-gp对ATP的补充,有效抑制P-gp的外排泵功能。由此可见,PTX@GO-PEG-OSA对PTX耐药的GC取得了更好的治疗效果,且无明显毒性。总之,PTX@GO-PEG-OSA可以作为逆转PTX耐药性的理想策略,与化学/光热/光动力疗法相结合。在线版本包含补充材料,可通过10.1186/s12951-021-00874-9获得。
Paclitaxel (PTX) has been suggested to be a promising front-line drug for gastric cancer (GC), while P-glycoprotein (P-gp) could lead to drug resistance by pumping PTX out of GC cells. Consequently, it might be a hopeful way to combat drug resistance by inhibiting the out-pumping function of P-gp. In this study, we developed a drug delivery system incorporating PTX onto polyethylene glycol (PEG)-modified and oxidized sodium alginate (OSA)-functionalized graphene oxide (GO) nanosheets (NSs), called PTX@GO-PEG-OSA. Owing to pH/thermal-sensitive drug release properties, PTX@GO-PEG-OSA could induced more obvious antitumor effects on GC, compared to free PTX. With near infrared (NIR)-irradiation, PTX@GO-PEG-OSA could generate excessive reactive oxygen species (ROS), attack mitochondrial respiratory chain complex enzyme, reduce adenosine-triphosphate (ATP) supplement for P-gp, and effectively inhibit P-gp’s efflux pump function. Since that, PTX@GO-PEG-OSA achieved better therapeutic effect on PTX-resistant GC without evident toxicity. In conclusion, PTX@GO-PEG-OSA could serve as a desirable strategy to reverse PTX’s resistance, combined with chemo/photothermal/photodynamic therapy. The online version contains supplementary material available at 10.1186/s12951-021-00874-9.
肿瘤微环境响应型中空介孔Co9S8@MnO2-ICG/DOX智能纳米平台协同增强肿瘤多模式治疗
DOI: 10.1016/j.biomaterials.2020.120346
发表时间: 2020-12-01
期刊: BIOMATERIALS
影响因子: 14
作者:
Huang, Junqing;Huang, Yao;Zeng, Songjun
通讯作者: Zeng, Songjun
DOI: 10.1016/j.cmet.2012.07.015
发表时间: 2012-09-05
期刊: CELL METABOLISM
影响因子: 29
作者:
Balsa, Eduardo;Marco, Ricardo;Antonio Enriquez, Jose
通讯作者: Antonio Enriquez, Jose
DOI: 10.1002/adma.202002439
发表时间: 2020-09-11
期刊: ADVANCED MATERIALS
影响因子: 29.4
作者:
Dong, Shuming;Dong, Yushan;Lin, Jun
通讯作者: Lin, Jun
墨鱼墨汁纳米颗粒通过协同免疫疗法和光热疗法抑制肿瘤生长
DOI: 10.1021/acsnano.9b02993
发表时间: 2019-08-01
期刊: ACS NANO
影响因子: 17.1
作者:
Deng, Rong-Hui;Zou, Mei-Zhen;Zhang, Xian-Zheng
通讯作者: Zhang, Xian-Zheng
DOI: 10.1002/smll.201700703
发表时间: 2017-08-25
期刊: SMALL
影响因子: 13.3
作者:
Chiang, Min-Yu;Lin, Yi-Zhen;Chen, San-Yuan
通讯作者: Chen, San-Yuan